Morepen Labs successfully raises Rs.200 crore through QIP

Funding Innovation and Growth via Capacity Expansion for Future endeavor Gurugram (Haryana) [India] August 7: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288), proudly announces the successful subscription of a Qualified Institutional Placement (QIP) for Rs. 200 crores. This strategic move underscores Morepen’s commitment to accelerating growth, enhancing institutional participation, increasing market presence, and improvement in […]

Continue Reading

Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

New Delhi [India], May 25: Morepen Laboratories Limited (NSE: OREPENLAB, BSE: 500288), a leading player in the Medical Devices (Point of Care) and Active Pharmaceutical Ingredients (API) sector, is pleased to announce its impressive financial results for the fourth quarter of the fiscal 2023-24. Marking its 40th year of a remarkable journey, Morepen has demonstrated […]

Continue Reading

Morepen Laboratories Limited’ Q3 FY24 EBITDA Surges by 151 per cent, Net Profit Records a Remarkable 256 per Growth

Mumbai (Maharashtra) [India], February 5: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products. The Company reported its unaudited Q3FY24 financial results. Key Financial Highlights (Consolidated): Consolidated Key Financial Highlights Q3 FY24: […]

Continue Reading